Move to topTop

Contributing to Society through Healthcare

Takahito Mimura, Chairman of the Board and Representative Director, and Shinjiro Sato, President and CEO
Takayoshi Mimura
Chairman of the Board
Shinjiro Sato
President and CEO

We express our deepest condolences for those who have passed away due to COVID-19 and pray for the quick recovery of all people who have been infected.

Terumo has collaborated closely as a Group with medical professionals on the front lines battling COVID-19, while also working to keep healthcare going for patients with other illnesses. We have found in these efforts a reconfirmation of the true meaning of the Terumo Group Mission-Contributing to Society through Healthcare—and of our purpose as a corporate citizen-to solve the challenges of medical settings.

Many signs of the post-COVID era are appearing around the world, but even before this pandemic, the world of healthcare was in need of transformation. This global crisis has accelerated that transformation, and a paradigm shift is expected in healthcare.

On September 17, 2021, Terumo celebrated its 100th anniversary. Looking ahead to the next 100 years, we will go beyond old paradigms to also create value in this new healthcare reality and contribute to medical settings and patients.

*Effective April 1, 2022, Toshiaki Takagi has been appointed as Chairman of the Board and Takayoshi Mimura has been appointed as Director and Corporate Advisor.